Mind the Byte presents strategic plan through 2020

Mind the Byte held its annual general meeting on 20 June at the Barcelona Science Park, presenting an ambitious strategic growth plan for the bioinformatics company through 2020.

Over these four years, Mind the Byte proposes to float shares on the British Alternative Investment Market (AIM), see revenue of at least ten million euros and position the company as a benchmark in computational design for the whole drug development process, both through its SaaS platform (Software as a Service) and with personalised services for companies (biotech and pharma), research centres and universities.

The company has launched the second version of its SaaS platform this year, with six new programs that have been warmly received by the scientific community.

This growth will be based on internationalisation and innovation. In terms of the former, the company is committed to introducing its products in Scandinavia, the United Kingdom, Canada, Korea and Japan, so it will boost its presence at the top fairs and congresses in the sector, among other actions. In September and October of this year, Mind the Byte will participate in BioJapan, Nordic Life Science Days and BioSpain 2016.

Regarding innovation, the company's work will focus on expanding its area of knowledge to find solutions to scientific problems detected using new algorithms and adding new features to the SaaS platform. It will also increase collaboration with companies and academia (open innovation) and incorporate new industrial post-docs to ensure transfer from university and attract new talent. Mind the Byte has participated in the Government of Catalonia Industrial Doctorates Plan since 2014 and has agreements with the Universitat Politècnica de Catalunya - BarcelonaTech (UPC) and the University of Vic - Central University of Catalonia (UVic-UCC).

The Spanish financial newspaper Expansión published an article with this news.

Photo: Board of directors of Mind the Byte